ArticleFrontiers in immunology2025

Antimycobacterial and immunomodulatory activities of sorafenib in a preclinical mouse model of TB infection through CD4

Raju S Rajmani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.